Companies
/Healthcare
iRhythm Technologies Inc
$107.71
▲ $1.03 (+0.97%) today
Markets closed · 10:55pm ET
24/7 Wall St. View
IRTC at a Glance
Valuation
- Market cap
- $3.5B
Profitability
- Revenue (TTM)
- $825.3M
- Profit margin
- -1.7%
- EPS (TTM)
- $-0.42
Price
- 52-week range
- $101 – $212
- 24/7 target
- $177.08
- Street target
- $173.93
Earnings
- Next report
- Oct 29, 2026
Headquartered in San Francisco, CA Fiscal year ends December NASDAQ: IRTC irhythmtech.com
About iRhythm Technologies
iRhythm Holdings, Inc. is a digital health care company focused on creating solutions that detect, predict, and prevent disease, with a primary focus on cardiac monitoring. The company combines its Zio wearable biosensors with cloud-based data analytics and proprietary AI-powered algorithms to distill data from millions of heartbeats into clinically actionable information. iRhythm serves cardiologists, primary care physicians, and health systems through its ambulatory cardiac monitoring platform. The company is expanding into predictive arrhythmia solutions using AI-driven analytics, and with its pending acquisition of VitalConnect, aims to broaden into mobile cardiac telemetry, multi-vitals monitoring, and hospital-to-home care settings, evolving into a comprehensive cardiac monitoring and intelligence platform. Updated
Frequently Asked Questions
What does iRhythm Technologies do?
iRhythm Holdings, Inc. is a digital health care company focused on creating solutions that detect, predict, and prevent disease, with a primary focus on cardiac monitoring.
What is the IRTC stock price target?
24/7 Wall St.'s 12-month price target for IRTC is $177.08, rated Buy. The Wall Street consensus target is $173.93. IRTC price prediction →